BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 16167426)

  • 1. Reticulate Hyperpigmentation secondary to 5-fluorouracil and idarubicin.
    Jogi R; Garman M; Pielop J; Orengo I; Hsu S
    J Drugs Dermatol; 2005; 4(5):652-6. PubMed ID: 16167426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Idarubicin-induced pigmentary changes of the nails.
    Borecky DJ; Stephenson JJ; Keeling JH; Vukelja SJ
    Cutis; 1997 Apr; 59(4):203-4. PubMed ID: 9104543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy-Related Reticulate Hyperpigmentation: A Case Series and Review of the Literature.
    Masson Regnault M; Gadaud N; Boulinguez S; Tournier E; Lamant L; Gladieff L; Roche H; Guenounou S; Recher C; Sibaud V
    Dermatology; 2015; 231(4):312-8. PubMed ID: 26422424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnostic image (92). A man with fever during chemotherapy. Invasive pulmonary mycosis].
    van Spronsen DJ; Daenen SM; Kluin-Nelemans JC
    Ned Tijdschr Geneeskd; 2002 Jun; 146(24):1126. PubMed ID: 12092303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Capecitabine-induced hyperpigmentation].
    Vázquez-Bayo C; Rodríguez-Bujaldón AL; Jiménez-Puya R; Galán-Gutiérrez M; Moreno-Giménez JC
    Actas Dermosifiliogr; 2007 Sep; 98(7):491-3. PubMed ID: 17669305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metallic taste as a side effect of topical fluorouracil use.
    Han SY; Youker S
    J Drugs Dermatol; 2011 Oct; 10(10):1201-3. PubMed ID: 21968673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of capecitabine-induced hyperpigmentation and radiation recall phenomenon.
    Ghosal N; Misra V
    Clin Oncol (R Coll Radiol); 2009 Oct; 21(8):632. PubMed ID: 19304468
    [No Abstract]   [Full Text] [Related]  

  • 8. Images in clinical medicine. Serpentine supravenous hyperpigmentation.
    Chan CC; Lin SJ
    N Engl J Med; 2010 Jul; 363(5):e8. PubMed ID: 20830826
    [No Abstract]   [Full Text] [Related]  

  • 9. Capecitabine induced cutaneous hyperpigmentation: report of a case.
    Pui JC; Meehan S; Moskovits T
    J Drugs Dermatol; 2002 Sep; 1(2):202-5. PubMed ID: 12847748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antineoplastic agent-associated serpentine supravenous hyperpigmentation: superficial venous system hyperpigmentation following intravenous chemotherapy.
    Geddes ER; Cohen PR
    South Med J; 2010 Mar; 103(3):231-5. PubMed ID: 20134385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can we improve outcomes in patients with acute myelogenous leukemia? Incorporating HDAC inhibitors into front-line therapy.
    Garcia-Manero G
    Best Pract Res Clin Haematol; 2012 Dec; 25(4):427-35. PubMed ID: 23200539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pressure-induced bullae and sweat gland necrosis following chemotherapy induction.
    Lane JE; Brown CA; Lesher JL; Hashem B; Marzec T
    Am J Med; 2004 Sep; 117(6):441-3. PubMed ID: 15380504
    [No Abstract]   [Full Text] [Related]  

  • 13. Atypical moles in a patient undergoing chemotherapy with oral 5-fluorouracil prodrug.
    Fukushima S; Hatta N
    Br J Dermatol; 2004 Sep; 151(3):698-700. PubMed ID: 15377362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical ethics collides with public policy: LVAD for a patient with leukemia.
    McCarthy PM; Lamm RD; Sade RM
    Ann Thorac Surg; 2005 Sep; 80(3):793-8. PubMed ID: 16122431
    [No Abstract]   [Full Text] [Related]  

  • 15. Serpentine supravenous streaks induced by 5-fluorouracil.
    Jain V; Bhandary S; Prasad GN; Shenoi SD
    J Am Acad Dermatol; 2005 Sep; 53(3):529-30. PubMed ID: 16112371
    [No Abstract]   [Full Text] [Related]  

  • 16. Cutaneous reactions to chemotherapeutic drugs and targeted therapies for cancer: part I. Conventional chemotherapeutic drugs.
    Reyes-Habito CM; Roh EK
    J Am Acad Dermatol; 2014 Aug; 71(2):203.e1-203.e12; quiz 215-6. PubMed ID: 25037800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adding lomustine to idarubicin and cytarabine for induction chemotherapy in older patients with acute myeloid leukemia: the BGMT 95 trial results.
    Pigneux A; Perreau V; Jourdan E; Vey N; Dastugue N; Huguet F; Sotto JJ; Salmi LR; Ifrah N; Reiffers J
    Haematologica; 2007 Oct; 92(10):1327-34. PubMed ID: 18024370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lingual hyperpigmentation after 5-fluorouracil chemotherapy.
    Co ML; Esteban MJ
    BMJ Case Rep; 2017 Apr; 2017():. PubMed ID: 28433985
    [No Abstract]   [Full Text] [Related]  

  • 19. Colitis associated to chemotherapy with 5-fluorouracil.
    Trevisani F; Simoncini M; Alampi G; Bernardi M
    Hepatogastroenterology; 1997; 44(15):710-2. PubMed ID: 9222677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy: Lo and behold, a role for lomustine in acute myeloid leukemia?
    Appelbaum FR
    Nat Rev Clin Oncol; 2010 Nov; 7(11):619-21. PubMed ID: 20981126
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.